Exploratory clinical trials evaluating the usefulness of fecal calprotectin as a monitoring of Crohn's disease using MR enterography

Exploratory clinical trials evaluating the usefulness of fecal calprotectin as a monitoring of Crohn's disease using MR enterography - Exploratory clinical trials evaluating the usefulness of fecal calprotectin as a monitoring of Crohn's disease using MR enterography

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034576

Enrollment

Registered

2019-10-22

Start date

2018-09-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are undergoing crohn's disease

Exclusion criteria

Exclusion criteria: Patient who can not obtain written informed consent

Design outcomes

Primary

Measure	Time frame
Fecal Calprotectin values	—

Secondary

Measure	Time frame
Fecal Calprotectin values, Crohn's disease clinical activity Index score, blood test every 2 months Small bowel lesions with MRE at start	—

Countries

Japan

Contacts

Public ContactYuka Fukuo

Juntendo University Nerima Hospital Gastroenterology

yfukuo@juntendo.ac.jp03-5923-3111

Outcome results